IRIS
PICONE, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.780
EU - Europa 1.640
NA - Nord America 1.485
SA - Sud America 223
AF - Africa 60
OC - Oceania 2
Totale 5.190
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.444
SG - Singapore 887
RU - Federazione Russa 716
CN - Cina 460
NL - Olanda 343
DE - Germania 255
BR - Brasile 179
HK - Hong Kong 114
IT - Italia 106
VN - Vietnam 100
IN - India 88
FI - Finlandia 76
KR - Corea 53
GB - Regno Unito 46
CI - Costa d'Avorio 29
FR - Francia 20
MX - Messico 17
JP - Giappone 15
CA - Canada 14
AR - Argentina 13
BD - Bangladesh 13
PL - Polonia 13
UA - Ucraina 13
EC - Ecuador 11
TR - Turchia 10
AT - Austria 8
IE - Irlanda 7
SE - Svezia 7
IQ - Iraq 6
ZA - Sudafrica 6
IL - Israele 5
LT - Lituania 5
PK - Pakistan 5
PY - Paraguay 5
EG - Egitto 4
ES - Italia 4
ID - Indonesia 4
JO - Giordania 4
KE - Kenya 4
PE - Perù 4
RS - Serbia 4
BE - Belgio 3
CL - Cile 3
GH - Ghana 3
UY - Uruguay 3
VE - Venezuela 3
CR - Costa Rica 2
DZ - Algeria 2
GT - Guatemala 2
HU - Ungheria 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MA - Marocco 2
MK - Macedonia 2
NO - Norvegia 2
OM - Oman 2
PH - Filippine 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BO - Bolivia 1
BW - Botswana 1
CD - Congo 1
CG - Congo 1
CM - Camerun 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GP - Guadalupe 1
GR - Grecia 1
IS - Islanda 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
ML - Mali 1
MU - Mauritius 1
MY - Malesia 1
NC - Nuova Caledonia 1
NI - Nicaragua 1
PF - Polinesia Francese 1
PR - Porto Rico 1
PT - Portogallo 1
RE - Reunion 1
RO - Romania 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
Totale 5.190
Salva come PNG Salva come JPEG
Città #
Secaucus 458
Singapore 454
Amsterdam 332
Hefei 250
Moscow 186
Santa Clara 117
Hong Kong 112
Munich 109
Ashburn 104
Chandler 91
Beijing 89
Seoul 53
Helsinki 52
Naples 52
Los Angeles 42
Kochi 40
Ho Chi Minh City 38
San Jose 29
New York 27
The Dalles 26
Hanoi 24
Buffalo 22
São Paulo 20
Milan 18
Redondo Beach 16
Frankfurt am Main 15
Boston 14
Karlsruhe 14
Pune 14
Seattle 14
Lawrence 13
Millbury 13
Poplar 13
Rome 13
Chennai 12
Dallas 12
London 12
Tokyo 11
Freiburg im Breisgau 10
Orem 10
Falkenstein 9
Mexico City 9
Nuremberg 9
Chicago 8
Denver 8
Lappeenranta 8
Warsaw 8
Houston 7
Turku 7
Ankara 6
Atlanta 6
Brasília 6
Jyväskylä 6
Krefeld 6
Paris 6
Quito 6
Stockholm 6
Brooklyn 5
Columbus 5
Düsseldorf 5
Haiphong 5
Montreal 5
Phoenix 5
Rio de Janeiro 5
Schoenwalde 5
Thái Nguyên 5
Zhengzhou 5
Amman 4
Baghdad 4
Boardman 4
Campinas 4
Kronberg 4
Nairobi 4
Querétaro 4
San Francisco 4
Toronto 4
Bengaluru 3
Biên Hòa 3
Brussels 3
Cairo 3
Caxias do Sul 3
Curitiba 3
Delhi 3
Edinburgh 3
Foggia 3
Gorssel 3
Harbin 3
Johannesburg 3
Kagoya 3
Lima 3
Manchester 3
Roccasecca 3
Rochdale 3
Rottweil 3
Tel Aviv 3
Accra 2
Asunción 2
Belo Horizonte 2
Bình Dương 2
Bắc Giang 2
Totale 3.225
Salva come PNG Salva come JPEG
Nome #
A 24-weeks real-world experience of dupilumab in adolescents with moderate-to-severe atopic dermatitis 972
Effect of Dupilumab on Sexual Desire in Adult Patients with Moderate to Severe Atopic Dermatitis 259
A Case of New-Onset Lichen Planus after COVID-19 Vaccination 182
Guselkumab, Risankizumab, and Tildrakizumab in the Management of Psoriasis: A Review of the Real-World Evidence 144
Psoriasiform dermatitis induced by dupilumab successfully treated with upadacitinib 115
Urticaria Relapse after mRNA COVID-19 vaccines in patients affected by chronic spontaneous urticaria and treated with antihistamines plus omalizumab: a single-center experience 115
A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years 114
A case of psoriatic alopecia secondary to certolizumab pegol: clinical and trichoscopic evaluation 110
Psoriatic Alopecia and Paradoxical Psoriasis Induced by Adalimumab Successfully Treated with Certolizumab: Clinical, Trichoscopic, and in vivo Reflectance Confocal Microscopy Features 106
A case of linear psoriasis in a young patient with Down syndrome and review of the literature 106
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part II: focus on elderly patients 106
Dupilumab for the treatment of atopic dermatitis in transplant patients: Two case reports and literature review 105
Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part I: focus on pediatric patients 103
The impact of COVID ‐19 infection on psoriatic patients treated with biologics: an Italian experience 103
Impact of COVID-19 pandemic and the use of telemedicine on the diagnosis and treatment of Tinea Corporis: An experience of Southern Italy center 102
Herpes zoster after ChAdOx1 nCoV-19 vaccine: a case series 102
Chondroid Syringoma: an asymptomatic benign tumour 99
Herpes Zoster and Alopecia Areata following mRNA BNT162b2 COVID-19 vaccine: Controversial immune effects 98
Generalized versus localized vitiligo after ixekizumab: May previous treatment affect the clinical presentation? 97
Can COVID-19 cause atypical forms of pityriasis rosea refractory to conventional therapies? 96
“Covid arm”: Abnormal side effect after Moderna COVID-19 vaccine 95
Vitiligo during dupilumab therapy 94
Paradoxical Hidradenitis Suppurativa during Biologic Therapy, an Emerging Challenge: A Systematic Review 94
An overview of new and emerging antibody therapies for moderate-severe atopic dermatitis in adults 93
Efficacy and Drug Survival of Tralokinumab in Severe Atopic Dermatitis: An 18-Month Multicenter Experience 92
A case of erythrodermic psoriasis rapidly and successfully treated with Bimekizumab 92
Reply to 'Burnout and professional quality of life in dermatologists' 90
How Adalimumab Impacts Antibiotic Prescriptions in Patients Affected by Hidradenitis Suppurativa: A 1-Year Prospective Study and Retrospective Analysis 89
A case of herpes zoster ophthalmicus after third dose of Comirnaty (BNT162b2 mRNA) vaccine 87
Technostress: The impact of technology on Italian dermatologists' burnout 86
Airborne allergic contact dermatitis "by proxy" due to budesonide 86
How to decrease systemic corticosteroids in pemphigus patients under rituximab 86
A case of acne fulminans successfully treated with photodynamic therapy 85
Injection site reactions resulting from the use of biological therapy in the treatment of moderate-to-severe plaque psoriasis 83
Hidradenitis suppurativa flares following COVID-19 vaccination: A case series 82
Role of aryl hydrocarbon receptor activation in inflammatory chronic skin diseases 80
Dupilumab for the treatment of adult atopic dermatitis in special populations 79
Comparison of Long-Term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis Between Dupilumab-Exposed and Dupilumab-Naïve Patients 78
Injections Site Reactions and Biologics for Psoriasis: A Questionnaire Based Real Life Study 78
Reply to Borgia et al. Comment on “Marasca et al. Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications. J. Clin. Med. 2022, 11, 1511” 71
A Rare Type of Radiation-Induced Alopecia: Proton-Induced Alopecia 69
Ulcerated morphea: the importance of the wound care 64
"PiMa sign": A possible correlation between dermographism and pityriasis versicolor? 54
Upadacitinib for the management of severe alopecia areata in adolescent patients: a single-centre retrospective study 51
A case of multiple basal cell carcinomas in an immunocompromised skin district: The aetiopathogenetic role of congenital lymphqedema 48
Totale 5.240
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.672
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.672
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022106 0 0 0 0 0 13 3 3 5 0 37 45
2022/2023392 13 11 34 53 39 35 11 46 65 45 23 17
2023/2024357 14 37 73 12 12 43 9 52 8 6 69 22
2024/20251.680 61 55 32 20 57 126 190 139 92 184 614 110
2025/20262.705 323 786 303 337 508 411 37 0 0 0 0 0
Totale 5.240